Junichi Shimizu

4.1k total citations
120 papers, 2.4k citations indexed

About

Junichi Shimizu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Junichi Shimizu has authored 120 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 57 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Junichi Shimizu's work include Lung Cancer Treatments and Mutations (54 papers), Lung Cancer Research Studies (31 papers) and Colorectal Cancer Treatments and Studies (15 papers). Junichi Shimizu is often cited by papers focused on Lung Cancer Treatments and Mutations (54 papers), Lung Cancer Research Studies (31 papers) and Colorectal Cancer Treatments and Studies (15 papers). Junichi Shimizu collaborates with scholars based in Japan, United States and South Korea. Junichi Shimizu's co-authors include Yoshitsugu Horio, Toyoaki Hida, Yasushi Yatabe, Tetsuya Mitsudomi, Yuko Oya, Hiroaki Kuroda, Yukinori Sakao, Tatsuya Yoshida, Kimihide Yoshida and Kosuke Tanaka and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Junichi Shimizu

107 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junichi Shimizu Japan 26 1.5k 1.3k 391 336 256 120 2.4k
Evan B. Douple United States 26 710 0.5× 667 0.5× 433 1.1× 166 0.5× 95 0.4× 72 2.3k
Shigeki Sato Japan 31 863 0.6× 751 0.6× 939 2.4× 250 0.7× 228 0.9× 150 3.0k
Yoon Young Choi South Korea 31 1.6k 1.1× 760 0.6× 510 1.3× 226 0.7× 189 0.7× 116 3.4k
Jun‐ichi Ogawa Japan 33 1.3k 0.9× 871 0.7× 1.1k 2.9× 303 0.9× 190 0.7× 209 3.7k
Xuesong Li China 30 940 0.6× 565 0.4× 876 2.2× 502 1.5× 183 0.7× 261 3.3k
Guilhem Bousquet France 27 672 0.4× 812 0.6× 542 1.4× 465 1.4× 106 0.4× 116 2.7k
Chia‐Hsun Hsieh Taiwan 28 366 0.2× 906 0.7× 398 1.0× 365 1.1× 119 0.5× 150 2.5k
Roberto Coppola Italy 32 870 0.6× 1.5k 1.2× 567 1.5× 206 0.6× 322 1.3× 196 3.4k
Martin Eichhorn Germany 31 901 0.6× 1.0k 0.8× 966 2.5× 316 0.9× 130 0.5× 129 3.0k
Matthew Foote Australia 28 608 0.4× 859 0.6× 215 0.5× 86 0.3× 350 1.4× 131 2.4k

Countries citing papers authored by Junichi Shimizu

Since Specialization
Citations

This map shows the geographic impact of Junichi Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Shimizu more than expected).

Fields of papers citing papers by Junichi Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Shimizu. The network helps show where Junichi Shimizu may publish in the future.

Co-authorship network of co-authors of Junichi Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Shimizu. A scholar is included among the top collaborators of Junichi Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Shimizu. Junichi Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasegawa, Takaaki, Toru Okuyama, Takehiro Uemura, et al.. (2024). Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer. Supportive Care in Cancer. 32(7). 421–421.
2.
Jänne, Pasi A., Toshio Kubo, Kiichiro Ninomiya, et al.. (2024). Trastuzumab deruxtecan (T-DXd) in patients with HER2-mutant metastatic non–small cell lung cancer (mNSCLC): Final analysis results of DESTINY-Lung02.. Journal of Clinical Oncology. 42(16_suppl). 8543–8543. 4 indexed citations
3.
Fujiwara, Yutaka, Katsuhiro Masago, Teppei Yamaguchi, et al.. (2024). Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report. SHILAP Revista de lepidopterología. 17(1). 942–949.
4.
5.
Jänne, Pasi A., Yasushi Goto, Toshio Kubo, et al.. (2023). MA13.10 Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer: Primary Results of DESTINY-Lung02. Journal of Thoracic Oncology. 18(11). S148–S148. 2 indexed citations
6.
7.
Yatabe, Yasushi, Kuniko Sunami, Kōichi Goto, et al.. (2020). Multiplex gene‐panel testing for lung cancer patients. Pathology International. 70(12). 921–931. 36 indexed citations
8.
Araki, Mitsugu, Katsuhiro Masago, Shiro Fujita, et al.. (2020). Novel Resistance Mechanisms Including L1196Q, P1094H, and R1248_D1249 Insertion in Three Patients With NSCLC After ALK Tyrosine Kinase Inhibitor Treatment. Journal of Thoracic Oncology. 16(3). 477–482. 6 indexed citations
9.
Takeda, Masayuki, Yuichiro Ohe, Hidehito Horinouchi, et al.. (2019). Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma. Lung Cancer. 137. 64–70. 10 indexed citations
10.
Hayakawa, Naoki, Iriya Muneta, T. Ohashi, et al.. (2018). Reduction of conductance mismatch in Fe/Al2O3/MoS2system by tunneling-barrier thickness control. Japanese Journal of Applied Physics. 57(4S). 04FP13–04FP13. 3 indexed citations
11.
Yamaguchi, Teppei, Junichi Shimizu, Takaaki Hasegawa, et al.. (2018). Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis. Lung Cancer. 125. 212–217. 111 indexed citations
12.
Shimizu, Junichi, T. Ohashi, Iriya Muneta, et al.. (2018). Low-Temperature MoS2 Film Formation Using Sputtering and H2S Annealing. IEEE Journal of the Electron Devices Society. 7. 2–6. 10 indexed citations
13.
Tanaka, Kosuke, Toyoaki Hida, Yuko Oya, et al.. (2015). EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma. Journal of Thoracic Oncology. 10(12). 1720–1725. 54 indexed citations
14.
Houtani, Takeshi, Yuji Yamashita, Junichi Shimizu, et al.. (2012). Cholinergic Fibers and Muscarinic Receptors in the Central Auditory System. 63. 7–9.
15.
Yoshida, Kimihide, Yasushi Yatabe, Park Jangchul, et al.. (2009). Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations. Journal of Cancer Research and Clinical Oncology. 136(4). 527–535. 11 indexed citations
16.
Hida, Toyoaki, et al.. (2008). Gefitinib for the treatment of non-small-cell lung cancer. Expert Review of Anticancer Therapy. 9(1). 17–35. 49 indexed citations
17.
Horio, Yoshitsugu, Junichi Shimizu, Hirotaka Osada, et al.. (2007). The mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity of cisplatin, carboplatin and gemcitabine in human lung cancer cell lines. Molecular Cancer Therapeutics. 6. 1 indexed citations
18.
Suda, Yoshihito, et al.. (2004). Tracheoesophageal Puncture with Tracheal Tube and Flexible Endoscope. Nippon Jibiinkoka Gakkai Kaiho. 107(12). 1033–1037. 3 indexed citations
19.
Shimizu, Junichi. (1996). Transient mechanical alternans component always exists in postextrasystolic potentiation with and without compensatory pause. Circulation. 94(1). 5 indexed citations
20.
Shimizu, Junichi, et al.. (1990). The effect of low power laser irradiation around the stellate ganglion. Nippon Laser Igakkaishi. 11(Supplement). 553–556. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evan B. Douple Breakdown of academic impact, for papers by Shigeki Sato Breakdown of academic impact, for papers by Yoon Young Choi Breakdown of academic impact, for papers by Jun‐ichi Ogawa Breakdown of academic impact, for papers by Xuesong Li Breakdown of academic impact, for papers by Guilhem Bousquet Breakdown of academic impact, for papers by Chia‐Hsun Hsieh Breakdown of academic impact, for papers by Roberto Coppola Breakdown of academic impact, for papers by Martin Eichhorn Breakdown of academic impact, for papers by Matthew Foote
Rankless by CCL
2026